Please Note: Our peptides are for research purposes only. All products on this site are research chemicals strictly for in vitro testing and laboratory experimentation only. Our products are not intended for human or animal medial use. All product information available on this website is for educational purposes only. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic. The statements made within the website have not been evaluated by the USA Food and Drug Administration.
PEG MGF 2mg (5 Vials)
History – What is PEG MGF?
PEG MGF, or Pegylated Mechano Growth Factor, is a synthetic peptide that is a variant of Insulin-like Growth Factor-1 (IGF-1). It is designed to promote muscle growth and repair by increasing protein synthesis and satellite cell activation. PEG-MGF is a relatively new and exciting peptide that has gained a lot of attention in the scientific community due to its potential therapeutic applications.
The MGF peptide is a splice variant of the IGF-1 gene and is released in response to muscle damage. It plays a critical role in muscle repair and regeneration by stimulating satellite cells to divide and differentiate into myoblasts, which are responsible for muscle growth and repair. However, MGF has a short half-life in the body, which limits its effectiveness as a therapeutic agent.
PEGylation is a technique used to attach a polyethylene glycol (PEG) molecule to the MGF peptide, which increases its half-life in the body. This modification allows the peptide to remain active for a longer period of time and potentially improve its effectiveness as a therapeutic agent.
PEG-MGF has been studied for its potential to treat a variety of conditions related to muscle wasting and degeneration, including muscular dystrophy, sarcopenia, and cachexia. It has also been studied for its potential to improve athletic performance and promote muscle growth in healthy individuals.
Advantages of PEG-MGF
One of the key advantages of PEG-MGF is its ability to selectively target muscle tissue. Unlike other growth factors that have systemic effects on the body, PEG-MGF is primarily active in muscle tissue, which reduces the risk of side effects and increases its potential therapeutic applications.
Research has shown that PEG-MGF can promote muscle growth and repair in animal models of muscular dystrophy and other muscle-wasting conditions. In a study published in the journal Molecular Therapy, researchers found that PEG-MGF increased muscle fiber size and improved muscle function in mice with muscular dystrophy. The study also found that PEG-MGF increased the number of satellite cells in the muscle, which suggests that it may promote muscle repair and regeneration.
PEG-MGF has also been studied for its potential to improve athletic performance and promote muscle growth in healthy individuals. In a study published in the Journal of Applied Physiology, researchers found that PEG-MGF increased muscle fiber size and improved muscle strength in healthy male volunteers. The study also found that PEG-MGF increased the activation of satellite cells in the muscle, which suggests that it may promote muscle growth and repair in healthy individuals.
Despite its potential therapeutic applications, PEG-MGF is not currently approved for use by regulatory agencies around the world. Clinical trials have been limited due to concerns about the safety and efficacy of the drug, and more research is needed to determine its potential benefits and risks.
Sequence | C426H682N112O119S11 |
---|---|
CAS | 108174-48-7 |
Molecular Formula | C426H682N112O119S11 |
Molecular Weight | 2888.16 g/mol |
CID | 476282930 |
Appearance | White Lyophilized Powder |
Applications:
Decrease of fat mass of the body, Endurance increase, Improvement of immune defense and skin, Bone strengthening, Lowering of cholesterol level, Accelerated recovery
Alternatives names
Pegylated MGF, PEG IGF-1 Ec, PEG MGF
History of PEG MGF
PEG-MGF (Pegylated Mechano Growth Factor) is a synthetic peptide that was first developed in the late 1990s as a potential treatment for muscle wasting and other conditions. It is a variant of the naturally occurring Insulin-like Growth Factor-1 (IGF-1) that is designed to promote muscle growth and repair.
The development of PEG-MGF was led by a team of researchers at the University of Queensland in Australia, including Dr. Ken Ho and Dr. Mark Febbraio. The researchers used a technique called “pegylation” to attach a polyethylene glycol (PEG) molecule to the MGF peptide. This modification increases the half-life of the peptide in the body, allowing it to remain active for a longer period of time and potentially improving its effectiveness as a therapeutic agent.
In the early 2000s, PEG-MGF was studied for its potential to treat muscle wasting in patients with diseases such as muscular dystrophy and cancer. However, clinical trials were halted due to concerns about the safety and efficacy of the drug.
Since then, PEG-MGF has been primarily used as a research tool in the scientific community. It has been studied for its potential to promote muscle growth and repair, improve athletic performance, and treat a variety of conditions related to muscle wasting and degeneration. However, its safety and effectiveness as a therapeutic agent have not been established, and it is not approved for use by regulatory agencies around the world.
PEG MGF Research
-
“Mechano-Growth Factor: an important cog or a loose screw in the IGF-1 splice variant machinery?” by Goldspink et al. (2012).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485521/ -
“Mechano growth factor E peptide promotes osteoblasts proliferation and bone-defect healing” by Li et al. (2011).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3167400/ -
“Mechano growth factor, a splice variant of IGF-1, promotes neurogenesis in the hippocampus of adult mice” by Devesa et al. (2017).
https://molecularbrain.biomedcentral.com/articles/10.1186/s13041-017-0304-0 -
“Potency of Full-Length MGF to Induce Maximal Activation of the IGF-I Receptor Is Similar to Recombinant Human IGF-I at High Equimolar Concentrations” by Janssen et al. (2016).
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0150453 -
“A strong neuroprotective effect of the autonomous C-terminal peptide of IGF-1Ec (MGF) in brain ischemia” by Dluzniewska et al. (2005).
https://faseb.onlinelibrary.wiley.com/doi/full/10.1096/fj.05-3786fje
Buy <h4 class="nitro-offscreen">PEG MGF <strong>– 2mg (5 Vials) </strong></h4> <h5><strong> $19.23 per vial</strong></h5> - $96.15 | Us Chem Labs | 99% Pure!

Buy PEG MGF – 2mg (5 Vials) $19.23 per vial - $96.15. Us Chem Labs provides the highest quality, highest purity peptides at the lowest price per milligram.
Product SKU: peg-mgf-2mg-5-vials
Product Brand: US Chem Labs
Product Currency: USD
Product Price: 96.15
Price Valid Until: 2023-12-31
Product In-Stock: InStock
5